Cargando…

Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy

Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jianbo, Wang, Hong, Liu, Ying, Li, Wen, Kim, Dorothy, Huang, Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363713/ https://www.ncbi.nlm.nih.gov/pubmed/25821590 http://dx.doi.org/10.1155/2015/605946

Ejemplares similares

Diabetic retinopathy and vascular endothelial growth factor
por: Khazaei, Majid
Publicado: (2013)

Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy
por: Ji, Liyang, et al.
Publicado: (2023)

Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020)

Targeting vascular leakage in lung inflammation
por: Li, Liang, et al.
Publicado: (2015)

Formyl Peptide Receptor Activation Elicits Endothelial Cell Contraction and Vascular Leakage
por: Wenceslau, Camilla F., et al.
Publicado: (2016)

Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
por: Chen, Hui-Jin, et al.
Publicado: (2019)

Tofacitinib Ameliorates Retinal Vascular Leakage in a Murine Model of Diabetic Retinopathy with Type 2 Diabetes
por: Byrne, Eimear M., et al.
Publicado: (2021)

Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity
por: Goswami, Binita, et al.
Publicado: (2015)

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy
por: Selim, Kocabora M, et al.
Publicado: (2010)

Vascular Endothelial Growth Factor Gene Polymorphism is not Associated with Diabetic Retinopathy in Egyptian Patients
por: Abdel Fattah, Rana Ahmed, et al.
Publicado: (2016)

Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy
por: Ahuja, Sukriti, et al.
Publicado: (2019)

Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
por: Huang, Hu, et al.
Publicado: (2011)

Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
por: Lopatko Fagerström, Ingrid, et al.
Publicado: (2019)

Topical nerve growth factor prevents neurodegenerative and vascular stages of diabetic retinopathy
por: Zerbini, Gianpaolo, et al.
Publicado: (2022)

How to target vascular leakage in retinopathy: could a lipid tighten the pipes?
por: Iruela‐Arispe, M Luisa
Publicado: (2023)

Association of the Pattern of Retinal Capillary Non-Perfusion and Vascular Leakage with Retinal Neovascularization in Proliferative Diabetic Retinopathy
por: Jung, Eric E., et al.
Publicado: (2021)

Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy
por: Qu, Qiang, et al.
Publicado: (2022)

Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy
por: Petrovič, Mojca Globočnik, et al.
Publicado: (2008)

Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
por: Zhao, Yue, et al.
Publicado: (2018)

Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
por: Wu, Lihteh, et al.
Publicado: (2019)

Axial myopia, a protective factor for diabetic retinopathy-role of vascular endothelial growth factor
por: Kulshrestha, Ashish, et al.
Publicado: (2022)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Methicillin-resistant Staphylococcus aureus-induced vascular leakage is associated with excessive production of nitric oxide and vascular endothelial growth factor
por: Enkhbaatar, Perenlei, et al.
Publicado: (2007)

Blockade of vascular endothelial growth factor receptor 2 inhibits intraplaque haemorrhage by normalization of plaque neovessels
por: de Vries, M. R., et al.
Publicado: (2018)

Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
por: Wang, Juanjuan, et al.
Publicado: (2010)

Fluorescence Angiography with Dual Fluorescence for the Early Detection and Longitudinal Quantitation of Vascular Leakage in Retinopathy
por: Pomeroy, Benjamin, et al.
Publicado: (2023)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
por: Muhiddin, Habibah Setyawati, et al.
Publicado: (2020)

Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes
por: Yang, Xiufen, et al.
Publicado: (2011)

Increased levels of vascular endothelial growth factor in aqueous humor of patients with diabetic retinopathy: Is it the whole truth?
por: Santhan Gopal, K S
Publicado: (2011)

MicroRNA-200b Regulates Vascular Endothelial Growth Factor–Mediated Alterations in Diabetic Retinopathy
por: McArthur, Kara, et al.
Publicado: (2011)

Vascular Endothelial Growth Factor in Anterior Chamber Liquid Patients with Diabetic Retinopathy, Cataract and Neovascular Glaucoma
por: Kuzmin, Anatoly, et al.
Publicado: (2013)

Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy
por: Gao, Xinxiao, et al.
Publicado: (2015)

Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy
por: Jung, Byung Ju, et al.
Publicado: (2019)

Relationship between Serum Vascular Endothelial Growth Factor Levels and Stages of Diabetic Retinopathy and Other Biomarkers
por: Abu-Yaghi, Nakhleh E., et al.
Publicado: (2020)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
por: Chatziralli, Irini, et al.
Publicado: (2021)

Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy
por: Ou, Shih-Hsiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fm42r2hqg3a0sbu20palgj2um6